Discover iLife

“iLife Discoveries : The Genetics and Genomics Company”

iLife Discoveries is a leading genetics & molecular diagnostics company with R&D initiatives in healthcare.

Established in 2008, the company specializes in molecular based diagnosis and gene based targeted therapies with an aim to diagnose disease at the genetic level that will enable patients to benefit from cost effective and personalized diagnostic tools and assist clinicians to offer the most appropriate and effective treatment to patients.

Developed with specialized skills and know-how that have been accumulated over the years, our genetic services are considered as superior in multiplex testing efficiency and cost effectiveness for cancer care and management, pharmacogenomics of neuro psychiatric drugs, prenatal and post natal assessment of genetic abnormalities , new born screening for IEMs(Inborn errors of Metabolism), congenital heart disorders and an increasing number of tests aimed to determine hereditary genetic predisposition and prognosis.

iLife Discoveries uses a variety of cutting-edge molecular based technologies to develop novel diagnostic assays including, but not limited to, Comparative Genomic Hybridization (CGH), Gene Expression Arrays, and Quantitative Polymerase Chain Reaction (qPCR).

At iLife Discoveries, we provide high quality services with fast turnaround time thereby meeting our client’s stringent requirements without compromising on the quality, reliability and confidentiality.

Our panels of consultants consist of world renowned geneticists and American college of Medical Genetics (ACMG) certified cytogeneticists, leading oncologists & molecular biologists.

Besides genetic diagnostic services, iLife Discoveries offers custom research services for national and global research organizations, academia and pharma companies. iLife Discoveries is a trusted scientific partner for many national and international R&D projects due to its innovation-driven approach and long lasting services.

To develop and facilitate the latest solutions and advances in genetics thereby transforming healthcare from retrospective, interventional care to perspective, preventive care that is highly personalized and pre-emptive enabling pre-symptomatic diagnosis, personalized therapy and drug dosages.
To be a trusted partner in diagnosis, known to introduce & facilitate the personalized approach to the current healthcare paradigm.
As a young entrepreneur from San Francisco Bay Area, the epicenter of technology, I have very closely witnessed the innovations in the field of Healthcare and Biotechnology sectors. Today, the advancements in genomic testing has made possible not only to predict the disease outcome but even the course of treatment.

I have always felt that I had a longstanding commitment to serve my country. With a mission to help my people live happier& healthier lives, I established iLife Discoveries, The Genetics & Genomics Company to bring the brewing innovation in diagnostic testing from Silicon Valley in my homeland.

As a company, we fundamentally believe –

“Your DNA is yours, you own it, and you should have access to It – It’s our mission to tell you everything science can.”

Our goal is to offer a tailored or personalized approach to treatment based on the molecular analysis of genes, proteins, and metabolites.

Since many cancer drugs come along with undesirable and severe side effects; personalized treatments intend to minimize such effects and maximize the outcome for each patient thereby avoiding therapies that will have none or only little effects on the tumor.

This approach is not limited to cancer treatment; better patient treatment is achieved through innovative and advanced diagnostic tests that will give a prognosis for an individual patient in terms of responder or non-responder to a certain therapy at the same time identifying the best possible drug and therapy.

Healthcare is changing – We are changing it for better!

As we seek to serve our patients — to provide an exceptional environment for our employees and affiliated physicians and an attractive return to our shareholders — we are guided by five core values:

  • Innovation and Leadership: The advancement of medical care is fueled by passionate individuals and committed organizations. As an innovative genomic & genetic diagnostic company, iLife Discoveries embraces a unique opportunity and deep responsibility to create new solutions for the challenges and opportunities in the current healthcare scenario.
  • Quality: Quality is at the core of everything we do and every decision we make.
  • Service: We have a culture of service that values teamwork and focuses on the needs of others.
  • Integrity & Ethical Behavior: We manage our business with integrity and the highest ethical standards.
  • Transparency: We operate with transparency by sharing results and outcomes.

We improve the lives we touch, through the delivery of high quality healthcare and everyday compassion.”

iLife discoveries team is highly experienced in genetic diagnostics and has demonstrated success in the field of genomics, companion diagnostics, and functional cell assays. The team has a proven track record in the industry and has developed strong relationships with key academic institutions, oncologists, and medical centers worldwide.
With an aim to introduce advanced molecular innovation to the bedside of patients, iLife Discoveries, the Genetics & Genomics Company has entered in technological alliance with leading diagnostic companies worldwide like Agendia, AB Biotics, Ovagene Oncology etc. to commercialize the specialized tests like MammaPrint, BluePrint, Neuropharmagen, Ovagene Oncology test suite tec. Exclusively in Indian Subcontinent.

7 copy